DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Altace (Ramipril) - Adverse Event Reports - All Cases - Hypotension

 



Index of reports > All cases (182) > Cases with Hypotension (21)

Below is the selection of adverse event reports related to Altace (Ramipril) that includes all cases where reactions include hypotension.

Adverse event in receiving Altace (Ramipril)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-31

Patient:

Adverse reactions / side effects: Renal Failure, Vomiting, Dehydration, Hypotension, Abdominal Distension, Circulatory Collapse, Pancreatitis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Altace
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Hypertension

Clozapine
    Administration route: Oral

Simvastatin
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Hypercholesterolaemia

Zaponex
    Administration route: Oral

Other drugs received by patient: Amisulpride; Atenolol; Aspirin



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-17

Patient:

Adverse reactions / side effects: Hypotension, Rectal Haemorrhage, Gastric Ulcer

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Dosage: 1 u film-coated tablet
    Administration route: Oral
    Indication: Cardiac Failure

Altace
    Dosage: 1 u, qd
    Administration route: Oral
    Indication: Hypertension

Elisor
    Dosage: 1 u tablet,qd
    Administration route: Oral
    Indication: Hypercholesterolaemia

Lasix
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Previscan / 00789001 /
    Dosage: 25 mg, qd
    Administration route: Oral
    Indication: Thrombosis
    End date: 2006-10-13

Previscan / 00789001 /
    Start date: 2006-10-15



Adverse event in receiving Altace (Ramipril)

Reported by a physician from United States on 2007-07-17

Patient:

Adverse reactions / side effects: Vomiting, Haemorrhage Intracranial, Hypotension, Mental Status Changes, Neurological Examination Abnormal, Fall, Dysarthria, Skin Laceration, Syncope

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Altace

Norvasc

Oxycodone HCL

Toprol-XL

Warfarin Sodium
    Dosage: 3.7 mg, qd
    Start date: 2006-09-12



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-04-18

Patient:

Adverse reactions / side effects: Abdominal Pain, Arterial Haemorrhage, Syncope, Haemorrhage, Hypotension

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Thyroid Hormones



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-04-10

Patient:

Adverse reactions / side effects: Overdose, Hypotension, Blood Pressure Decreased, Haemodynamic Instability

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 300 mg, single
    Administration route: Oral

Ranitidine
    Dosage: 4500 mg, single
    Administration route: Oral

Simvastatin
    Dosage: 600 mg, single
    Administration route: Oral



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-03-16

Patient:

Adverse reactions / side effects: Hyperkalaemia, Nausea, Hypotension, Hyperhidrosis, Torsade DE Pointes, Malaise, Vertigo, Atrioventricular Block, Bradycardia, Blood Creatinine Increased, Blood Sodium Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Aldactone
    Dosage: 150 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2005-05-15
    End date: 2006-10-13

Altace
    Dosage: 10 mg, qd
    Administration route: Oral

Other drugs received by patient: Corgard; Isoptin



Adverse event in receiving Altace (Ramipril)

Reported by a physician from United States on 2007-03-06

Patient:

Adverse reactions / side effects: Hypotension, Hypotonia, Dizziness, Hyperhidrosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 1.25 mg, qd
    Start date: 2006-10-26

Carvedilol
    Dosage: 6.5 mg, qd
    Start date: 2006-05-01

Spironolactone
    Dosage: 12.5 mg, qd
    Start date: 2006-10-26

Torasemid Sandoz
    Dosage: 5 mg, qd
    Start date: 2006-05-01

Other drugs received by patient: Simvastatin; Insulin; Aspirin; Clopidogrel



Adverse event in female receiving Altace (Ramipril)

Reported by a consumer/non-health professional from Germany on 2007-02-26

Patient: female

Adverse reactions / side effects: Intentional Overdose, Hypotension, Tachycardia, Suicide Attempt, Somnolence

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 10-15 mg, single
    Administration route: Oral
    Start date: 2007-01-28
    End date: 2007-01-28

Sonata
    Dosage: 35 mg, single
    Administration route: Oral
    Start date: 2007-01-28
    End date: 2007-01-28



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-02-22

Patient:

Adverse reactions / side effects: Overdose, Hypotension, Blood Pressure Decreased, Haemodynamic Instability

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 300 mg, single
    Administration route: Oral

Ranitidine
    Dosage: 4500 mg, single
    Administration route: Oral

Simvastatin
    Dosage: 600 mg, single
    Administration route: Oral



Adverse event in receiving Altace (Ramipril)

Reported by a physician from United Kingdom on 2007-02-20

Patient:

Adverse reactions / side effects: Rhabdomyolysis, Sensory Loss, Lactic Acidosis, Pallor, Partial Seizures, Overdose, Cardio-Respiratory Arrest, Oedema Peripheral, Tachypnoea, Apnoea, Abdominal Pain Lower, Vomiting, Metabolic Acidosis, Pain in Extremity, Hypotension, Compartment Syndrome, Body Temperature Decreased, Blood Lactic Acid Increased, Renal Impairment, Diarrhoea, Dehydration, LEG Amputation

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Alcohol / 00002101 /
    Dosage: 500 ml over 4 hours

Altace
    Dosage: 35 mg, single

Metformin
    Dosage: 56 g, single



Adverse event in female receiving Altace (Ramipril)

Reported by a consumer/non-health professional from Germany on 2007-02-09

Patient: female

Adverse reactions / side effects: Intentional Overdose, Hypotension, Tachycardia, Suicide Attempt, Somnolence

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 50 mg, single
    Administration route: Oral
    Start date: 2007-01-28
    End date: 2007-01-28

Sonata
    Dosage: 7 to 14 capsules or 35 to 70 mg, single
    Administration route: Oral
    Start date: 2007-01-28
    End date: 2007-01-28



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from China on 2007-02-07

Patient:

Adverse reactions / side effects: Hypotension, Pollakiuria, Polyuria, Cardiogenic Shock

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Furosemide
    Dosage: 20 mg, qd
    Indication: Cardiac Failure



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from China on 2007-02-07

Patient:

Adverse reactions / side effects: Hypotension, Pollakiuria, Polyuria, Cardiogenic Shock

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Furosemide
    Dosage: 20 mg, qd
    Indication: Cardiac Failure



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from China on 2007-02-07

Patient:

Adverse reactions / side effects: Death, Hypoproteinaemia, Hypotension, Pollakiuria, Polyuria, Azotaemia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Furosemide
    Dosage: 20 mg, qd
    Indication: Cardiac Failure



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from China on 2007-02-07

Patient:

Adverse reactions / side effects: Death, Hypoproteinaemia, Hypotension, Pollakiuria, Polyuria, Azotaemia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Furosemide
    Dosage: 20 mg, qd
    Indication: Cardiac Failure



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from China on 2007-02-07

Patient:

Adverse reactions / side effects: Hypotension, Pollakiuria, Polyuria, Cardiogenic Shock

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Furosemide
    Dosage: 20 mg, qd
    Indication: Cardiac Failure



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-02-05

Patient:

Adverse reactions / side effects: Pulmonary Hypertension, Right Ventricular Failure, Dyspnoea, Hypotension, Electromechanical Dissociation, Renal Failure, Cyanosis, Hypoxia, Hypertension, Shock, Venous Occlusion

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Altace
    Dosage: 10 mg, qd
    Administration route: Oral

Cellcept
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2005-07-16
    End date: 2006-12-09

Cozaar
    Dosage: 1 u, qd
    Administration route: Oral

Detensiel / 00802601 /
    Dosage: 10 mg, qd
    Administration route: Oral

Lercan
    Dosage: 1 u, qd
    Administration route: Oral
    End date: 2006-12-09

Rapamune
    Dosage: 4 mg, qd
    Administration route: Oral
    End date: 2006-12-09

Other drugs received by patient: Luteran



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-01-31

Patient:

Adverse reactions / side effects: Acute Pulmonary Oedema, Hypotension

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 1.25 mg, qd
    Administration route: Oral
    Start date: 2006-12-05
    End date: 2006-12-07

Cardensiel
    Dosage: 1.25 mg, qd
    Administration route: Oral
    Start date: 2006-12-05
    End date: 2006-12-06

Other drugs received by patient: Calciparine; Kardegic / 00002703 /; Ogast; Plavix; Zocor



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-01-30

Patient:

Adverse reactions / side effects: Arterial Disorder, Hypotension

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Kardegic / 00002703 /; Mediatensyl / 00631801 /; Doliprane; Skenan; Pravastatin; Plavix



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-01-26

Patient:

Adverse reactions / side effects: Renal Impairment, Chest Pain, Hypotension, Dizziness

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Hypertension

Altace
    Dosage: 5 mg, qd
    Administration route: Oral

Other drugs received by patient: Aspirin; Atenolol; Frusemide / 00032601 /; Isosorbide Mononitrate; Naproxen; Simvastatin



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-01-23

Patient:

Adverse reactions / side effects: Syncope, Hypotension, Vertigo, Bradycardia, Headache

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-01-01
    End date: 2005-07-01

Hydrochlorothiazide
    Dosage: 12.5 mg, qd
    Administration route: Oral
    Start date: 2005-01-01
    End date: 2005-07-01

Seloken / 00376902 /
    Dosage: unk, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2005-01-01
    End date: 2005-07-01

Other drugs received by patient: Coumadin; Pradif; Triniplas; Finastid; Polase / 00196901 /

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009